Introduction
============

Heme oxygenase (HO) is involved in heme catabolism, a process in which the oxidation of heme leads to the production of iron, biliverdin and carbon monoxide \[[@B1]\]. Three mammalian HO isozymes have been identified, one of which, HO-1, is a stress-responsive protein. HO-1 is highly inducible by a vast array of stimuli, including oxidative stress, heat shock, ultraviolet radiation, ischemia-reperfusion, heavy metals, bacterial lipopolysaccharide (LPS), cytokines, nitric oxide, and its substrate, heme \[[@B2]--[@B5]\]. This strong adaptive response of HO-1 to various stimuli suggests an entirely new paradigm by which HO-1 could play a significant role in protection against inflammatory processes and oxidative tissue injury.

Recent studies have extensively investigated the transcriptional factors and regulatory regions that are responsible for induction of the *ho-1* gene. Several signaling molecules (*e.g.*, mitogen-activated protein kinases (MAPK)) and transcriptional regulators (activator protein-1, NF-E2-related factor-2 (Nrf2), hypoxia-inducible factor-1 (HIF1) and Bach-1) participate in the regulation of the *ho-1* gene. In these molecules, accumulating data implicate Nrf2 as a key regulator of the adaptive response to oxidative stress \[[@B6]--[@B11]\] and of the transcriptional activation of *ho-1* \[[@B12]\]. Under normal conditions, Nrf2 localizes in the cytoplasm, where it interacts with Kelch-like ECH associating protein 1 (Keap1), and is rapidly degraded by the ubiquitin-proteasome pathway \[[@B13]\]. Namely, Keap1 acts as negative regulator of Nrf2. Various stimuli, including electrophiles and oxidative stress, liberate Nrf2 from Keap1, allowing Nrf2 to translocate into the nucleus and to bind to antioxidant-response elements (ARE) \[[@B14]\]. Nuclearly translocated Nrf2 provides immediate transactivation of regulated encoding genes. In this sequence of Nrf2 activation, the phosphorylation of Nrf2 is an important event in the dissociation of Nrf2 from Keap1 \[[@B15]--[@B17]\]. Thus the translocation of Nrf2 is considered a major defense mechanism that plays a key role in the induction of HO-1.

In this review, we focused on the expression of HO-1 associated with Nrf2 pathway by lansoprazole.

Anti-inflammatory Effects by Lansoprazole
=========================================

Proton pump inhibitors (PPIs) such as lansoprazole have dramatically influenced the management of acid-peptic disorders in recent years, and are extensively used to treat acid-related disorders, including gastroesophageal reflux disease and peptic ulcer disease caused by stress, non-steroidal anti-inflammatory drugs and *Helicobacter pylori* infection \[[@B18]--[@B21]\]. Lansoprazole is a strong anti-secretory agent that acts on gastric H^+^/K^+^-adenosine triphosphatase (H^+^/K^+^ ATPase) of parietal cells \[[@B22]\]. In addition to its acid-suppressing effects, lansoprazole have been shown to modulate the inflammatory status, reduce oxidative stress, and ameliorate mucosal injuries in the esophagus \[[@B23], [@B24]\], intestine \[[@B25], [@B26]\], and lung \[[@B27]\], in addition to the stomach \[[@B28], [@B29]\]. It has been also demonstrated by *in vitro* studies that lansoprazole inhibits the increased expression of vascular adhesion molecules, the activation of neutrophils, and the production of pro-inflammatory cytokines from activated endothelial cells \[[@B30], [@B31]\]. We recently demonstrated using *in vivo* models that lansoprazole inhibits acute inflammatory reactions as well as intestinal mucosal injuries induced by ischemia-reperfusion \[[@B25]\] or indomethacin administration in rats \[[@B26]\]. These intestinal injuries induced by ischemia-reperfusion or indomethacin were significantly inhibited by lansoprazole at a dose of 5 mg/kg together with significant suppression of the increased levels of thiobarbituric acid-reactive substances, myeloperoxidase activities and cytokine-induced neutrophil chemoattractant-1 (CINC-1) in the small bowel. Furthermore, the increased CINC-1 mRNA expression after ischemia-reperfusion or indomethacin administration was also inhibited by the treatment with lansoprazole. These results suggest that lansoprazole administered exogenously prevents the small intestine against ischemia-reperfusion or indomethacin-induced damage, the action being dependent on its anti-inflammatory and anti-oxidative responses. These data indicate the possibility that lansoprazole may prevents intestinal mucosal injury by mechanisms independent of acid inhibition.

HO-1 Expression Induced by Lansoprazole
=======================================

Our recent study using a DNA microarray clearly showed that lansoprazole induces several genes, including phase II detoxifying enzyme (NADPH-ubiquinone oxidoreductase, glutathione S-transferase) and antioxidant stress proteins (HO-1, thioredoxin reductase, and superoxide dismutase) in gastric epithelial cells (Naito, JCBN2007, http://www2. kpu-m.ac.jp/%7Efirstmed/GeneChip.html) \[[@B32]\]. As shown in Figure [1](#F1){ref-type="fig"}, we confirmed that lansoprazole induced HO-1 up-regulation in rat gastric epithelial cells. Incubation with lansoprazole (1 µM) induced expression of the *ho-1* gene in the early phase within 3 h of lansoprazole addition. In association with the induction of *ho-1* gene expression, the expression of the HO-1 protein was significantly increased in a time-dependent manner after lansoprazole treatment, and confocal microscopy revealed that the HO-1 protein was localized to the cytoplasm fraction. Becker *et al.* \[[@B28]\] also demonstrated that PPIs protect gastric epithelial cells against oxidative stress, and this protection is abrogated in the presence of an HO-1 inhibitor. Exposure to lansoprazole resulted in a strong induction of HO-1 expression on mRNA and protein level, and led to an increased activity of this enzyme. These data indicate that lansoprazole-induced HO-1 induction might account for the cytoprotective and anti-inflammatory effects of lansoprazole independent of acid-secretion inhibition.

Anti-Inflammatory Effect throughout HO-1 Induction by Lansoprazole
==================================================================

Rat CINC-1, a counterpart of the human growth-regulated oncogene (GRO), has been suggested to participate in neutrophil recruitment in an experimental model of gastritis in rat. Our previous report demonstrated that rat gastric epithelial cells (RGM-1 cells) produced CINC-1 in response to various pro-inflammatory cytokines, such as TNF-α, IL-1β, and bacterial LPS \[[@B30]\]. To confirm the anti-inflammatory effect of lansoprazole-induced HO-1 on RGM-1 cells, we measured the production of CINC-1 on RGM-1 cells using ELISA. As shown in Table [1](#T1){ref-type="table"}, pretreatment with lansoprazole significantly inhibited the production of CINC-1 from stimulated RGM-1 cells with IL-1β. In addition, the inhibition was reversed by co-treatment with the HO-1 inhibitor SnPP. These data indicate that the anti-inflammatory effect of lansoprazole is mediated through the induction of HO-1. On this basis, the up-regulation of HO-1 by lansoprazole contributes to the inhibition of chemokine production from stimulated gastric mucosal cells.

Role of Nrf2 in HO-1 Up-Regulation by Lansoprazole
==================================================

We used a small interfering RNA (siRNA) approach to determine if lansoprazole-mediated up-regulation of HO-1 was dependent on Nrf2 in RGM-1 cells. RGM-1 cells were transiently transfected with either control siRNA or siRNA directed against Nrf2. Thirty hour after transfection, cells were exposed to lansoprazole for 6 h, and then *ho-1* mRNA and HO-1 protein expression were examined by real-time PCR and Western blotting, respectively. Under these conditions, the treatment of RGM-1 cells with Nrf2-siRNA decreased the constitutive *ho-1* mRNA level and abolished the lansoprazole-induced *ho-1* mRNA (Table [2](#T2){ref-type="table"}) and HO-1 protein expression, suggesting a pivotal role of Nrf2 in the regulation of HO-1 in RGM-1 cells. These experiments demonstrate a direct correlation between Nrf2 and HO-1 expression and support the contention that lansoprazole-mediated up-regulation of HO-1 is Nrf2-dependent.

Conclusion
==========

In summary, lansoprazole up-regulated HO-1 expression throughout Nrf2 in rat gastric epithelial cells, and the up-regulated HO-1 had anti-inflammatory effects (Fig. [2](#F2){ref-type="fig"}) \[[@B33]\]. Further studies will be needed to clarify the mechanisms involved in this phenomenon in greater detail.
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![The expression of HO-1 induced by lansoprazole.\
RGM-1 cells were incubated with lansoprazole. (A) *ho-1* gene expression was measured using real-time PCR. The mRNA level of β*-actin* was determined simultaneously, and *HO-1/*β*-actin* ratio was calculated for each sample. Values represent the mean ± SEM (*n* = 4). ^\#^*p*\<0.05 compared to No stimulation (0 h) (B) Whole cell extracts were prepared and analyzed by immunoblotting with an antibody against HO-1. (C) The expression and the localization of HO-1 in RGM-1 cells 6 h after lansoprazole treatment was investigated using confocal microscopy.](jcbnSR09-28f01){#F1}

![Lansoprazole induced HO-1 expression throughout the translocation of Nrf2.](jcbnSR09-28f02){#F2}

###### 

The inhibition of CINC-1 production in RGM-1 cells treated with lansoprazole

  Treatment                                         CINC-1 production (pg/ml)
  ------------------------------------------------- ---------------------------
  Normal                                            13.4 ± 0.08
  IL-1β (1 ng/ml)                                   48.7 ± 8.72\*
  IL-1β (1 ng/ml) + Lansoprazole 1 µM               22.7 ± 1.21^\#^
  IL-1β (1 ng/ml) + Lansoprazole 1 µM + SnPP 1 µM   46.6 ± 4.71

Data represent the mean + SEM (*n* = 3). \**p*\<0.05 compared to normal group. ^\#^*p*\<0.05 compared to IL-1β stimulation group.

###### 

The effect of Nrf2-siRNA on HO-1 expression

  Treatment                          HO-1 mRNA expression (HO-1/β-actin)
  ---------------------------------- -------------------------------------
  Normal (Control RNAi)              1
  Lansoprazole 1 µM (Control RNAi)   1.62 ± 0.08\*
  Nrf2 RNAi                          0.85 ± 0.08
  Nrf2 RNAi + Lansoprazole 1 µM      1.19 ± 0.04^\#^

Data represent the mean + SEM (*n* = 3). \**p*\<0.05 compared to normal group. ^\#^*p*\<0.05 compared to Lansoprazole 1 µM (Control RNAi) group.
